Mr Kenneth Mark Grant, RPH | |
17577 Maxon Ln, Adams, NY 13605-2127 | |
(315) 232-4562 | |
(315) 232-3705 |
Full Name | Mr Kenneth Mark Grant |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 17577 Maxon Ln, Adams, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790007722 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 32190 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Kenneth Mark Grant, RPH 17577 Maxon Lane, Adams, NY 13605 Ph: (315) 232-4562 | Mr Kenneth Mark Grant, RPH 17577 Maxon Ln, Adams, NY 13605-2127 Ph: (315) 232-4562 |
News Archive
Researchers at the National Institutes of Health have created a mathematical model - and an accompanying online weight simulation tool - of what happens when people of varying weights, diets and exercise habits try to change their weight. The findings challenge the commonly held belief that eating 3,500 fewer calories - or burning them off exercising - will always result in a pound of weight loss.
Extracorporeal membrane oxygenation, a procedure traditionally used during cardiac surgeries and in the ICU that functions as an artificial replacement for a patient's heart and lungs, has also been used to resuscitate cardiac arrest victims in Japan, Taiwan, and South Korea.
Significant quality challenges persist in antipsychotic medication use for children in foster care and other Medicaid-insured children, according to a new Rutgers University-New Brunswick study published in Health Affairs.
Robert Prud'homme, professor of chemical and biological engineering at Princeton University, has been selected to receive the inaugural Dean for Research Award for Distinguished Innovation for the invention of flash nanoprecipitation, a method for creating nanoparticles that promises to improve the delivery of drugs throughout the body.
Arno Therapeutics, Inc. announced today that its Phase II clinical study of AR-67 has met pre-defined interim goals for patients with glioblastoma multiforme (GBM) who were not previously treated with Avastin and will continue toward completion.
› Verified 3 days ago
Ms. Stacie Flo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10923 Us Route 11, Adams, NY 13605 Phone: 315-232-4562 Fax: 315-232-3705 | |
Renee Dyer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10923 Us Route 11, Adams, NY 13605 Phone: 315-232-4562 Fax: 315-232-3705 | |
Dr. John Francis Peebles, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10412 Us Route 11, Apt #1, Adams, NY 13605 Phone: 315-778-8190 | |
Bessie Jones, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10923 Us Route 11, Adams, NY 13605 Phone: 315-232-4562 | |
Keith Crimmins, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10924 Us Route 11, Suite 3, Adams, NY 13605 Phone: 315-232-2460 Fax: 315-232-2482 |